Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Manqiqige Su"'
Autor:
Huahua Zhong, Xiao Huan, Rui Zhao, Manqiqige Su, Chong Yan, Jie Song, Jianying Xi, Chongbo Zhao, Feifei Luo, Sushan Luo
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-14 (2023)
Abstract Background Myasthenia gravis (MG) is the most prevalent autoimmune disorder affecting the neuromuscular junction. A rapid deterioration in respiratory muscle can lead to a myasthenic crisis (MC), which represents a life-threatening condition
Externí odkaz:
https://doaj.org/article/a4239e1daecf4466ae4bb09be2645a32
Autor:
Xiao Huan, Rui Zhao, Jie Song, Huahua Zhong, Manqiqige Su, Chong Yan, Ying Wang, Sheng Chen, Zhirui Zhou, Jiahong Lu, Jianying Xi, Sushan Luo, Chongbo Zhao
Publikováno v:
BMC Immunology, Vol 23, Iss 1, Pp 1-9 (2022)
Abstract Background Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular junctions. Cytokines play important roles in facilitating the immune response and augmenting the pathogenic antibody production. The current study aims to se
Externí odkaz:
https://doaj.org/article/2eadf365c5154810bd9e947fc185bffd
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 17, Iss 1, Pp 1-8 (2022)
Abstract Objective Myasthenia gravis (MG) is an autoimmune disorder that frequently affects females at reproductive age. Herein, we aimed to assess the associations of clinical factors with pregnancy-related outcome in MG. Methods We searched PubMed
Externí odkaz:
https://doaj.org/article/e3d8dc0a17124f38bf6529fbdfc5e35a
Autor:
Manqiqige Su, Shan Jin, Kexin Jiao, Chong Yan, Jie Song, Jianying Xi, Chongbo Zhao, Zhirui Zhou, Jianming Zheng, Sushan Luo
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 12 (2022)
IntroductionPatients with myasthenia gravis (MG) are prone to the development of pneumonia due to the long-term immunotherapies they receive and a tendency for aspiration. Pneumonia remains a risk factor for MG worsening and is the most prevalent cau
Externí odkaz:
https://doaj.org/article/4d6355e6c7ef43cdab1f4339c1240702
Autor:
Kexin Jiao, Dongyue Yue, Xinyu Gu, Nachuan Cheng, Xuechun Chang, Huahua Zhong, Xiao Huan, Manqiqige Su, Yufan Zhou, Sushan Luo, Chongbo Zhao, Jianying Xi, Wenhua Zhu
Publikováno v:
Stem Cell Research, Vol 64, Iss , Pp 102897- (2022)
Oculopharyngodistal myopathy (OPDM) is a late-onset degenerative muscle disorder characterized by ptosis and weakening of the facial, pharyngeal, and distal limb muscles. Our study reprogrammed human-induced pluripotent stem cells (iPSC) from the per
Externí odkaz:
https://doaj.org/article/febb7cdc98084f5eaeeb7bec42757f04
Autor:
Huahua Zhong, Kexin Jiao, Xiao Huan, Rui Zhao, Manqiqige Su, Li-Ying Goh, Xueying Zheng, Zhirui Zhou, Sushan Luo, Chongbo Zhao
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Background and objectivesMyasthenia gravis (MG) is a T cell-driven, autoantibody-mediated disorder affecting transmission in neuromuscular junctions. The associations between the peripheral T cells and MG have been extensively studied. However, they
Externí odkaz:
https://doaj.org/article/59a8c738301049bc94666ad2977555eb
Autor:
Huahua Zhong, Xiao Huan, Kexin Jiao, Shen He, Zhu Wen, Rui Zhao, Li-Ying Goh, Manqiqige Su, Jie Song, Chong Yan, Jianying Xi, Xueying Zheng, Zhirui Zhou, Sushan Luo, Chongbo Zhao
Publikováno v:
Autoimmunity reviews. 22(1)
The interrelationship between mental health and autoimmunity gains more and more attention in recent years. However, the causality between personality traits and autoimmune diseases remained largely unknown.We first conducted two-sample mendelian ran
Publikováno v:
Orphanet journal of rare diseases. 17(1)
Objective Myasthenia gravis (MG) is an autoimmune disorder that frequently affects females at reproductive age. Herein, we aimed to assess the associations of clinical factors with pregnancy-related outcome in MG. Methods We searched PubMed and EMBAS
Publikováno v:
Autoimmunity reviews. 21(1)
Chimeric antigen receptor (CAR) based therapies have been adopted as an option for treating autoimmune diseases from the field of blood malignancies by targeting immune cells or rebalancing the pro-inflammatory milieu. Important questions still remai